Sangamo BioSciences, Inc. (SGMO)

Q4 2011 Earnings Call

February 8, 2012 5:00 p.m. ET

Executives

Elizabeth J. Wolffe, Ph.D. – Senior Director, Corporate Communications

Edward O. Lanphier II – President and Chief Executive Officer

H. Ward Wolff – Executive Vice President and Chief Financial Officer

Geoffrey M. Nichol, M.B., Ch.B. – Executive Vice President, Research and Development

Philip D. Gregory, D. Phil. - Vice President of Research and Chief Science Officer

Dale Ando, M.D. - Vice President, Therapeutic Development and Chief Medical Officer

Analysts

Joseph Schwartz - Leerink Swann

Charles Duncan - JMP Securities

Ted Tenthoff - Piper Jaffray

Liana Moussatos - Wedbush Securities

Alastair Mackay - GARP Research

Presentation

Operator

Good afternoon and welcome to the Sangamo BioSciences teleconference to discuss fourth quarter and full-year 2011 financial results. This call is being recorded. I will now pass you over to the coordinator for this event, Dr. Elizabeth Wolffe, Senior


Complete Story »